Healthcare -
Biotechnology - NASDAQ - US
$ 1.05
2.94 %
$ 57.8 M
Market Cap
-0.59
P/E
PRLD - TOTAL EQUITY
Total Equity PRLD - Prelude Therapeutics Incorporated
237 M
LAST VALUE
-8.93%
2 YEAR CAGR
65.58%
5 YEAR CAGR
0.00%
10 YEAR CAGR